Medidata

@Medidata

Powering the development of new therapies for over 1,000 companies with our unified platform, pioneering analytics and unrivaled expertise

New York, NY
Vrijeme pridruživanja: ožujak 2009.

Tweetovi

Blokirali ste korisnika/cu @Medidata

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Medidata

  1. Prikvačeni tweet
    9. sij

    We're thrilled to come back to ! Hear from our as she shares her excitement and make sure to come meet our team at booth #805!

    Poništi
  2. prije 6 sati

    : tune in as our Mark Glover, shares his journey in the industry w/ . How it all started + the passion that keeps him focused on outcomes driven through and w/ pros:

    Poništi
  3. prije 8 sati

    : In a survey with we discovered that 84% of senior executives agree that represents a new era in drug development, highlighting the need for data-centric tools & a connected ecosystem. More info here:

    Poništi
  4. prije 10 sati

    : , on behalf of Medidata, conducted a finding that 90% of ClinOps personnel say their workload related to oversight has increased. Find out why in the first of a four-part series:

    Poništi
  5. prije 12 sati

    : Join our , Matt Noble, as he kicks off a session on implementation case studies such as digital in & a wearable sensor platform in a trial.

    Poništi
  6. prije 15 sati

    : “We believe that we need to continue to strive to do better,” says Lyndsay Harris, Head of Global CSR and ESG reporting at Medidata, in our latest podcast. Watch here:

    Poništi
  7. 4. velj

    : Check out ’s interview with via ahead of on how new technologies used in could accelerate the number of new drugs.

    Poništi
  8. 4. velj

    : Watch as our talks about his presentation from w/ re the use of synthetic control arms in + the success his team had in replicating a control group using a synthetic approach in multiple myeloma study:

    Poništi
  9. 4. velj

    : We're thrilled to see our strategic business development, Sheila Diamond, celebrated by as one of their women leadership in immuno-oncology group. Congrats, Sheila 👏🏼🎉

    Poništi
  10. 4. velj

    : Are site-less, de-centralized or virtual trials the same model? In this session, our SVP, , joins an expert panel to discuss , the technology behind it & specific challenges in retaining patients + investigators:

    Poništi
  11. 3. velj

    On-Demand : How do we efficiently & effectively leverage vast datasets to gain insights & visibility into patient treatments & outcomes? Watch to see how a connected platform unifies disparate data sources:

    Poništi
  12. 3. velj

    Download this to learn about our , Medidata Rave Clinical Cloud & how it drives by tackling management challenges and improves overall operational efficiencies.

    Poništi
  13. 3. velj

    : Having a strategic roadmap to navigate & meet the requirements for is a crucial step in the process. In this session, Sharon Ayd shares her expert knowledge of how to navigate + submit correct forms and meet requirements:

    Poništi
  14. 3. velj

    : Meet Marc. His team has many responsibilities, one of which is to evaluate + update stakeholders on the state of quality for the products/services we release. See how our mission has impacted him… maybe he is after all 🦇 🦸🏻

    Poništi
  15. 3. velj

    : Join our real-world data expert Marc Berger as he kicks off a session focused on how using real-world evidence can improve design as well as using in regulatory settings.

    Poništi
  16. 3. velj

    : "It's our responsibility as a company to really have an impact," says Lyndsay Harris, Head of Global CSR and ESG reporting at Medidata, in our latest podcast. Watch here:

    Poništi
  17. 2. velj

    : Following an investment pledge by the British Prime Minister into NHS AI lab, our gm & svp, EMEA, shared his thoughts on the subject matter incl. challenges & future developments in w/

    Poništi
  18. 2. velj

    : In this issue of , our shares his perspective on how play a pivotal role in the future of digital for the industry. See what other technologies are making an impact & driving change:

    Poništi
  19. 1. velj

    : It's essential for patients to have a clear understanding of all aspects during a . In this session, , a 3x + trial volunteer will draw from & share her perspective :

    Poništi
  20. 1. velj

    Sponsors and CROs face challenges when it comes to managing, reporting + executing . As the only end-to-end global site payment solution, Rave Site Payments integrates with any to trigger payments quickly and accurately. Learn more here:

    Poništi
  21. 31. sij

    : In a survey with we discovered that 84% of senior executives agree that represents a new era in drug development, highlighting the need for data-centric tools & a connected ecosystem. More info here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·